CLINTEX: Share clinical trials data without any threat to security
Every invention has its unique creation which includes a supporter and a naysayer. This is evidently visible across the technology and medical field, and in the general life too. Every decision you take has the potential to change the discourse of your career, and they require focus and concentration. The primary importance in our life is our health, so in many of the decisions, we take in our life we evaluate it based on our survival. The medical technology has progressed and produced many solutions to the diseases which were incurable a few decades back. One of the most important parts in the development and launch of the drug is the clinical trials, which decides the effects and the quality and to check whether it is safe enough to be launched in the mass market.
The problem is the high cost involved in the process which is divided into many phases. And the fragmentation of the market and different regulating standards creates pressure on the pharmaceutical companies to produce costly drugs. One of the many ways in which we can solve the problem is through sharing the data among the companies for the clinical trials results. Do you think we can develop a solution for the challenges mentioned above?
Solution offered
CLINTEX CTI is the platform looking to solve the problem with the application of the blockchain technology. Creating an ecosystem of decentralized data sharing and analytics related to the clinical trials among the different pharmaceutical companies is the ultimate objective of the platform. Interoperability is the critical theme across the different services of the platform. Tracking data and its authenticity is the critical part of the plan because ultimately data is the force on which the drug development process depends.
Smart contracts capabilities are announced to simplify the transaction and contracts among companies regarding sharing the data. Smooth payment, data security, and immutable data records are a few of the many key elements of the platform. They are also utilizing the power of machine learning technology to secure and manage the clinical data. Real-time access to the data hub will be beneficial to all the participating pharmaceuticals companies.
ICO INFORMATION AND TEAM
50% of the CLX tokens are reserved for the public token sale. The exact dates for the token sale are yet to be announced. The funds will be utilized in the technology and platform development. The team working on the project has years of experience in the felid of medical technology and blockchain technology.
Conclusion
The future of the medical field is dependent on the drugs that we develop. The drugs we develop is dependent on the data that the clinical trials produce. The solution would be a collaborative effort by all the stakeholders of the industry. With the introduction of this platform, the players can gather data and share among themselves to develop innovative solutions. It may be made one of the basic requirements to get approval before launching any new drugs. Effects of the drugs in the clinical trials produce required data and results which can be processed to evaluate the performance of the drugs.
The world will be a better place with the concept of adapting the philosophy of sharing things among themselves. The data, the progress, the visualization and the transaction are all the key part of the services offered by the platform. Blockchain technology is the future, and it is intriguing to see the path forward taken by different companies to launch better services and innovative products. What do you think about the different products and services launched by the platform?
Website- https://www.clintex.io/
Whitepaper- https://www.clintex.io/Clintex_CTi_Whitepaper.pdf
Published By- Kishan748
Btalk Profile- https://bitcointalk.org/index.php?action=profile;u=1027561